Heron Therapeuti (HRTX)

Currency in USD
1.900
-0.020(-1.04%)
Closed·
After Hours
1.940+0.040(+2.11%)
·

HRTX Earnings

Latest Release
May 06, 2025
EPS / Forecast
0.01 / -0.02
Revenue / Forecast
38.90M / 34.25M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.01--/38.08M----Free Sign Up
03/20250.01/-0.0238.9M/34.25M+150%+13.58%Free Sign Up
12/20240.02/-0.0340.78M/37.3M+166.67%+9.33%Free Sign Up
09/2024-0.03/-0.0432.81M/36.61M+25%-10.38%Free Sign Up
06/2024-0.06/-0.0436.02M/36.09M-50%-0.19%Free Sign Up
03/2024-0.02/-0.0734.7M/32.81M+71.43%+5.76%Free Sign Up
12/2023-0.07/-0.1634.22M/31.14M+56.25%+9.89%Free Sign Up
09/2023-0.17/-0.2931.43M/32.75M+41.38%-4.03%Free Sign Up
06/2023-0.35/-0.2231.76M/31.7M-59.09%+0.19%Free Sign Up
03/2023-0.27/-0.2829.62M/30.84M+3.57%-3.96%Free Sign Up

All numbers in USD

Heron Therapeuti Earnings Call Summary for Q1/2025

  • Heron Therapeutics beats Q1 2025 expectations with EPS of $0.01 and revenue of $39 million, stock surges 10.8% in premarket trading
  • Company reports net income of $2.6 million and record quarterly adjusted EBITDA of $6.2 million, signaling turnaround from previous losses
  • Oncology products CINVONTI and SUSTAL generate combined net revenues of $28.6 million, driving overall revenue growth
  • Revised adjusted EBITDA guidance set at $4-12 million, with stronger growth anticipated in latter half of the year
  • CEO emphasizes focus on targeted growth for key assets ZENERALEV and OPONVI, aiming to expand market presence in orthopedic sector
Last Updated: 06/05/2025, 13:36
Read Full Transcript

FAQ

What Is Heron Therapeuti's Earnings Per Share (TTM)?

The Heron Therapeuti EPS (TTM) is -0.05.

When Is The Next Heron Therapeuti Earnings Date?

Heron Therapeuti will release its next earnings report on 11 Aug 2025.

What Is Heron Therapeuti’s Revenue Forecasts For Upcoming Quarters?

Heron Therapeuti’s revenue forecast is 38.08M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.